Beijing Sun-Novo Pharmaceutical Research Co. Ltd.SSE: 688621

for STC008 Injection

Apr 25, 2026 · Issued by Beijing Sun-Novo Pharmaceutical Research Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 25, 2026

On 6ix: 6ix.com/news/for-stc008-injection

Announcement on the Signing of the “Supplementary Agreement to the Technology Development Contract” for STC008 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix

Earlier from Beijing Sun-Novo Pharmaceutical Research

Announcement on Application for Comprehensive Credit Line and Estimated Amount of Guarantees by the Company and Its SubsidiariesApr 24
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of ABA001 InjectionApr 3
Announcement on Postponing Term Change of the Board of Directors and Resignation upon Term Expiration of Partial Independent DirectorsMar 21
Announcement on the Self-Inspection Report on Insider Trading During the Self-Inspection Period by Persons Aware of Material Non-public Information Related to the Termination of Issuance of Shares and Convertible Corporate Bonds to Acquire Assets, Raising Supporting Funds, and Related Party TransactionsMar 14
Announcement on Voluntary Disclosure of External InvestmentMar 10

Later from Beijing Sun-Novo Pharmaceutical Research

Announcement on Progress in Cooperation in Investment with a Private FundMay 9
Announcement on Completion of the Board of Directors' Re-election, Election of the Chairman and Members of Special Committees under the Board of Directors, and Appointment of Senior Management Member and Securities Affairs RepresentativeMay 16
Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for STC009 InjectionMay 23
Announcement on Progress in Signing of the "Supplementary Agreement to the Technology Development Contract" for STC008 InjectionMay 26
Announcement on Participation in the Establishment of Hangzhou Qizhen Zhikang Equity Investment Partnership (Limited Partnership)May 30

All Beijing Sun-Novo Pharmaceutical Research news releases

Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.

Follow Beijing Sun-Novo Pharmaceutical Research